Invention Grant
- Patent Title: RNAi inhibition of alpha-ENaC expression
-
Application No.: US15260824Application Date: 2016-09-09
-
Publication No.: US09914927B2Publication Date: 2018-03-13
- Inventor: Gino Van Heeke , Emma Hickman , Henry Luke Danahay , Pamela Tan , Anke Geick , Hans-Peter Vornlocher
- Applicant: Arrowhead Pharmaceuticals, Inc.
- Applicant Address: US CA Pasadena
- Assignee: Arrowhead Pharmaceuticals, Inc.
- Current Assignee: Arrowhead Pharmaceuticals, Inc.
- Current Assignee Address: US CA Pasadena
- Agent Robert Michael Teigen
- Priority: EP07110376 20070615; EP07114265 20070813
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/713 ; A61K45/06
Abstract:
The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.
Public/Granted literature
- US20160376599A1 RNAi Inhibition of Alpha-ENaC Expression Public/Granted day:2016-12-29
Information query
IPC分类:
